1) se was only observed in the high-exposure group. |
2) 1∶1 PSM, 46 cases were remained in each group. |
3) were 2.5 times as much as those of vector group. |
4) rmittent further increases in the RIPostC group. |
5) utcomes show large inequalities by social group. |
6) Both subjects belonged to the dCAIS group. |
7) d siRNA-THBS1+400 μmol/L eleutheroside E group. |
8) d siRNA-THBS1+400 μmol/L eleutheroside E group. |
9) d siRNA-THBS1+400 μmol/L eleutheroside E group. |
10) ingdom, making them an important priority group. |
11) tological findings of the diosmin-treated group. |
12) (43.2%), compared to 15.4% in the control group. |
13) ovements were noted only in the real-tDCS group. |
14) one set of sixty seconds for each muscle group. |
15) ry-perceptual task served as a comparison group. |
16) standard 6-month regimen in the low-risk group. |
17) ly ADL and TUG improved in the VE with OS group. |
18) en positions were found for the untrained group. |
19) ency (26%) when compared with the control group. |
20) is modified with medium-chain fatty acyl group. |
21) atigue significantly improved for the ONC group. |
22) benefits were estimated without a control group. |
23) determinants of vaccine hesitancy in this group. |
24) e government plans belonged to the second group. |
25) in the epididymides compared with the MD group. |
26) y are members of the nurses' wider social group. |
27) ound in the right cerebellum for the RSSD group. |
28) s relatively more abundant in the control group. |
29) nd the low level of MHL that affects this group. |
30) or work together as a coherent functional group. |
31) ignificantly higher than those of control group. |
32) use disorder in comparison to the no-SIA group. |
33) t not in the gonadal (P = 0.18) of the EX group. |
|